• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经调节素信号在肿瘤微环境中的作用。

Neuregulin Signaling in the Tumor Microenvironment.

机构信息

Fujian Provincial Key Laboratory of Transplant Biology, Affiliated Dongfang Hospital, Xiamen University School of Medicine, Fuzhou, Fujian Province, China.

Department of Urology, the 900th Hospital of the Joint Logistics Team, Fujian Medical University, Fuzhou, Fujian Province, China.

出版信息

Adv Exp Med Biol. 2021;1270:1-29. doi: 10.1007/978-3-030-47189-7_1.

DOI:10.1007/978-3-030-47189-7_1
PMID:33123990
Abstract

Neuregulins, members of the largest subclass of growth factors of the epidermal growth factor family, mediate a myriad of cellular functions including survival, proliferation, and differentiation in normal tissues through binding to receptor tyrosine kinases of the ErbB family. However, aberrant neuregulin signaling in the tumor microenvironment is increasingly recognized as a key player in initiation and malignant progression of human cancers. In this chapter, we focus on the role of neuregulin signaling in the hallmarks of cancer, including cancer initiation and development, metastasis, as well as therapeutic resistance. Moreover, role of neuregulin signaling in the regulation of tumor microenvironment and targeting of neuregulin signaling in cancer from the therapeutic perspective are also briefly discussed.

摘要

神经调节蛋白是表皮生长因子家族中最大亚类的生长因子成员,通过与 ErbB 家族的受体酪氨酸激酶结合,在正常组织中介导包括存活、增殖和分化在内的多种细胞功能。然而,肿瘤微环境中异常的神经调节蛋白信号被越来越多地认为是人类癌症起始和恶性进展的关键因素。在本章中,我们重点讨论神经调节蛋白信号在癌症特征中的作用,包括癌症起始和发展、转移以及治疗耐药性。此外,还简要讨论了神经调节蛋白信号在肿瘤微环境调节中的作用以及从治疗角度靶向神经调节蛋白信号在癌症中的作用。

相似文献

1
Neuregulin Signaling in the Tumor Microenvironment.神经调节素信号在肿瘤微环境中的作用。
Adv Exp Med Biol. 2021;1270:1-29. doi: 10.1007/978-3-030-47189-7_1.
2
The neuregulin-I/ErbB signaling system in development and disease.发育与疾病中的神经调节蛋白-I/表皮生长因子受体信号系统
Adv Anat Embryol Cell Biol. 2007;190:1-65.
3
Roles for neuregulins in human cancer.神经调节蛋白在人类癌症中的作用。
Clin Exp Metastasis. 2004;21(8):665-84. doi: 10.1007/s10585-004-6917-6.
4
ErbB-4 activation inhibits apoptosis in PC12 cells.ErbB-4激活可抑制PC12细胞的凋亡。
Neuroscience. 2001;107(2):353-62. doi: 10.1016/s0306-4522(01)00350-5.
5
Neuregulins and cancer.神经调节蛋白与癌症
Clin Cancer Res. 2008 Jun 1;14(11):3237-41. doi: 10.1158/1078-0432.CCR-07-5133.
6
The cellular response to neuregulins is governed by complex interactions of the erbB receptor family.细胞对神经调节蛋白的反应受erbB受体家族复杂相互作用的调控。
Mol Cell Biol. 1995 Oct;15(10):5770-6. doi: 10.1128/MCB.15.10.5770.
7
The achilles heel of ErbB-2/HER2: regulation by the Hsp90 chaperone machine and potential for pharmacological intervention.表皮生长因子受体2(ErbB-2/HER2)的致命弱点:热休克蛋白90(Hsp90)伴侣机制的调控及药物干预潜力
Cell Cycle. 2004 Jan;3(1):51-60.
8
PDCD4 limits prooncogenic neuregulin-ErbB signaling.PDCD4 限制致癌性神经调节蛋白-ErbB 信号。
Cell Mol Life Sci. 2021 Feb;78(4):1799-1815. doi: 10.1007/s00018-020-03617-5. Epub 2020 Aug 17.
9
Morphogenetic effects of neuregulin (neu differentiation factor) in cultured epithelial cells.神经调节蛋白(神经分化因子)对培养上皮细胞的形态发生作用。
Mol Biol Cell. 1998 Nov;9(11):3195-209. doi: 10.1091/mbc.9.11.3195.
10
[Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP].[肿瘤微环境中一种新的促侵袭因子的鉴定:细胞外ATP的功能与机制研究进展]
Beijing Da Xue Xue Bao Yi Xue Ban. 2017 Apr 18;49(2):188-195.

引用本文的文献

1
The Brain-Penetrant Pan-ErbB Inhibitor Poziotinib Effectively Targets HER2+ Breast Cancer Brain Metastases.可穿透血脑屏障的泛ErbB抑制剂波齐替尼有效靶向HER2阳性乳腺癌脑转移灶。
Cancer Res. 2025 Apr 15;85(8):1514-1529. doi: 10.1158/0008-5472.CAN-24-1793.
2
Overcoming brain-derived therapeutic resistance in HER2+ breast cancer brain metastasis.克服HER2阳性乳腺癌脑转移中的脑源性治疗耐药性。
bioRxiv. 2024 Feb 22:2024.02.19.581073. doi: 10.1101/2024.02.19.581073.